This shows that cystatin C, as a protease inhibitor, participates in many pathological and physiological processes of the cardiovascular system and may become a molecular indicator for auxiliary diagnosis and detection in the occurrence and rupture of intracranial aneurysms. The gene discussed is CST3; the disease is Dilatation of the cerebral artery.